| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 307 | 3.056 | 8.042 | 12.238 | 195 | 47 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 307 | 3.056 | 8.042 | 13.056 | 17.943 | 2.280 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 2.293 | 873 | 9.660 | 21.590 | 1.502 | 1.429 | 544 | 455 | 330 | 220 |
| Gross Profit/Loss - EUR | -1.986 | 2.183 | -1.618 | -8.534 | 16.441 | 851 | -544 | -455 | -330 | -220 |
| Net Profit/Loss - EUR | -1.996 | 2.091 | -1.859 | -8.926 | 15.902 | 782 | -544 | -455 | -330 | -220 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bio Vivo Nova Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 1.113 | 821 | 1.424 | 796 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 7.969 | 6.332 | 6.078 | 291 | 90 | 0 | 0 | 0 | 18 | 47 |
| Inventories | 222 | 220 | 216 | 90 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 7.746 | 6.102 | 5.742 | 201 | 90 | 0 | 0 | 0 | 18 | 47 |
| Cash | 1 | 10 | 120 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | -173.409 | -169.550 | -168.539 | -174.372 | -155.093 | -151.370 | -148.557 | -149.474 | -149.350 | -148.735 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 181.378 | 176.995 | 175.438 | 176.148 | 155.979 | 151.370 | 148.557 | 149.474 | 149.368 | 148.782 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Bio Vivo Nova Srl